Wild Type p73 Overexpression and High-Grade Malignancy in Breast Cancer
暂无分享,去创建一个
Mariano Provencio | Jose M. Silva | M. Provencio | J. García | Javier Silva | F. Bonilla | Javier Silva | Antonio Sanchez | Gemma Dominguez | Pilar España | Felix Bonilla | Antonia Navarro | Jose M. Garcia | Isabel Gallego | A. Navarro | Isabel Gallego | G. Domínguez | Antonio C. Sánchez | P. España | Antonia Navarro
[1] L. Holmberg,et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. , 1996, Journal of the National Cancer Institute.
[2] A. Nakagawara,et al. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. , 1998, International journal of oncology.
[3] Å. Borg,et al. Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. , 1992, Genes, chromosomes & cancer.
[4] F. Haluska,et al. Mutational and expression analysis of the p73 gene in melanoma cell lines. , 1999, Cancer research.
[5] Audenino Rg. [Malignant tumors of the breast]. , 1960, El Dia medico.
[6] D. Tindall,et al. Activation of p73 silent allele in lung cancer. , 1998, Cancer research.
[7] I. Bièche,et al. Two distinct regions involved in 1p deletion in human primary breast cancer. , 1993, Cancer research.
[8] A. Yang,et al. Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.
[9] F. Vikhanskaya,et al. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line. , 2000, Nucleic acids research.
[10] D. Tindall,et al. Overexpression of the wild type p73 gene in human bladder cancer , 1999, Oncogene.
[11] M. Genuardi,et al. Distal deletion of chromosome Ip in ductal carcinoma of the breast. , 1989, American journal of human genetics.
[12] W. Stolz,et al. Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas , 1998, Melanoma research.
[13] T. Zacharewski,et al. pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers , 1999, Breast Cancer Research and Treatment.
[14] S. Nomoto,et al. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. , 1998, Cancer research.
[15] U. Moll,et al. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. , 1999, Cancer research.
[16] G. Yang,et al. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. , 2000, Carcinogenesis.
[17] S. Chi,et al. Advances in Brief Elevated and Biallelic Expression of p 73 Is Associated with Progression of Human Bladder Cancer , 1999 .
[18] Carl W. Miller,et al. NEOPLASIA Loss of p 73 Gene Expression in Leukemias / Lymphomas Due to Hypermethylation , 1999 .
[19] F. McKeon,et al. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent , 1999, Oncogene.
[20] A. Nakagawara,et al. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. , 1998, Cancer Research.
[21] Å. Borg,et al. Chromosome I alterations in breast cancer: Allelic loss on Ip and Iq Is related to lymphogenic metastases and poor prognosis , 1992 .
[22] S. Swendeman,et al. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[23] C. Croce,et al. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. , 1995, Cancer research.
[24] 大藤 道衛. Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus , 1995 .
[25] J. Herman,et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. , 1999, Cancer research.
[26] M. P. Neal. MALIGNANT TUMORS OF THE MALE BREAST , 1933 .
[27] Yohko Nakamura,et al. Mutational analysis of the p73 Gene in human breast cancers , 1999, International journal of cancer.
[28] C. Prives,et al. p 53 Mutants in Mammalian Cells p 73 Function Is Inhibited by Tumor-Derived , 1999 .
[29] David I. Smith,et al. p73 mutations are not detected in sporadic and hereditary breast cancer , 1999, Breast Cancer Research and Treatment.
[30] H. Iwase,et al. [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[31] W. Kaelin,et al. p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.
[32] D. Housman,et al. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Byers,et al. Cadherin-11 is expressed in invasive breast cancer cell lines. , 1999, Cancer research.
[34] J. Pipas,et al. Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Sakurada,et al. Infrequent somatic mutations of the p73 gene in various human cancers. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[36] N. Nomura,et al. p73, a geme related to p53, is not mutated in esophageal carcinomas , 1998, International journal of cancer.
[37] K. Engeland,et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. , 1999, Journal of the National Cancer Institute.
[38] M. Broggini,et al. Allelic expression of p73 in human ovarian cancers. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[39] B. Leggett,et al. p73 Is up‐regulated in a subset of hepatocellular carcinomas , 2000, Hepatology.
[40] Xinbin Chen,et al. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. , 1998, Cancer research.
[41] W. Kaelin,et al. Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73 , 1998, Molecular and Cellular Biology.